Repurposing SGLT2 and DPP‐4 inhibitors for mild cognitive impairment in type 2 diabetes mellitus: Insights from proteomics, target prediction and molecular docking

Documenti analoghi

• Suppressing the background of LC–ESI–MS analysis of permethylated glycans using the active background ion reduction device
  di: Mojibola Fowowe, et al.
  Pubblicazione: (2024)
• Differential expression of N‐glycopeptides derived from serum glycoproteins in mild cognitive impairment (MCI) patients
  di: Cristian D. Gutierrez Reyes, et al.
  Pubblicazione: (2024)
• Evidence of Involvement of the Calcitonin Gene‐Related Peptide in Restless Legs Syndrome
  di: Maria P. Mogavero, et al.
  Pubblicazione: (2025)
• A novel methodology to determine the safe operating regime for an offshore wind‐integrated electrolysis system
  di: Ahmed Hamdy El‐Kady, et al.
  Pubblicazione: (2025)
• A Green GLANCE‐Assisted Spectrofluorimetric Method for the Nanogram‐Level Quantification of Terazosin, Singly and in Combination With Triamterene, With Therapeutic Drug Monitoring Applications: Greenness, Whiteness, and Blueness Assessment
  di: Rana Ghonim, et al.
  Pubblicazione: (2026)